Melodi Health is committed to transforming breast reconstruction through surgical innovation with the aim to meaningfully improve outcomes in a patient population that is undergoing complicated treatment regimens. Melodi's flagship offering, the Melodi Matrix, is based on proven technology from Medtronic. The Melodi Matrix is a bioabsorbable mesh that elutes antibiotic agents and is fully absorbed by the body. Melodi has licensed Medtronic technology for the breast surgery field of use.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/03/24 | $10,750,000 | Series A |
Engage Ventures HM Venture Partners Southeast Minnesota Capital Fund Three Bridges Ventures | undisclosed |
